Antibody treatment for MIS-C works by depleting inflammatory immune cells
NIH-funded study explains how intravenous immune globulin helps children with rare COVID condition.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Children | Gammagard Liquid | National Institutes of Health (NIH) | Privigen | Study